Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss (NCT07216924)

🧪 Interventions in This Study

• Personalised Remapping Training (BEHAVIORAL)
• RSVP personalized remappi (BEHAVIORAL)
• Reading text in the wild with remapping (BEHAVIORAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Minnesota — Edina, Minnesota

📞 Contact the Study Coordinator

Phone: (952) 285-2895

Email: engel@umn.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Macular Degeneration

• Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration — Mesa, Arizona
• Artificial Intelligence-assisted Diagnosis in Ophthalmology — Heredia, Centro
• A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) — Gilbert, Arizona
• A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT — Dallas, Texas
• Learning Study: Improving Vision in Adults With Macular Degeneration — Waterloo, Ontario

Explore by condition: All Macular Degeneration clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.